Quantum Biopharma (QNTM) Operating Expenses (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Operating Expenses data on file, last reported at $3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 12.69% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $14.9 million (up 11.88% YoY), and the FY2025 full-year result was $15.3 million, down 5.17% from the prior year.
• Operating Expenses advanced to $3.0 million in Q1 2026, from $2.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $9.8 million in Q1 2023 to a low of $1.9 million in Q2 2023.
• A 5-year average of $3.9 million and a median of $3.4 million in 2025 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 84.77% in 2024, while the deepest fall reached 77.07% in 2024.
• Tracing QNTM's Operating Expenses over 5 years: stood at $5.6 million in 2022, then sank by 41.38% to $3.3 million in 2023, then tumbled by 31.84% to $2.3 million in 2024, then grew by 5.14% to $2.4 million in 2025, then climbed by 24.98% to $3.0 million in 2026.
• Business Quant data shows QNTM's Operating Expenses at $3.0 million in Q1 2026, $2.4 million in Q4 2025, and $4.7 million in Q3 2025.